Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07332806

Site of Tracheal Extubation and Operating Room Efficiency During Robot-assisted Surgery

Led by Peking University First Hospital · Updated on 2026-01-15

218

Participants Needed

1

Research Sites

11 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to evaluate the impact of different extubation strategy on the occupancy time of operating room (OR) and the incidence of adverse events and quality of recovery after robotic-assisted surgery. The investigators hypothesize that extubation in the post-anesthesia care unit (PACU) may reduce OR occupancy time without increasing adverse events or worsening quality of recovery early after robotic-assisted surgery. This strategy may enhance perioperative efficiency while maintaining clinical safety.

CONDITIONS

Official Title

Site of Tracheal Extubation and Operating Room Efficiency During Robot-assisted Surgery

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18 years or older
  • Scheduled for elective robot-assisted laparoscopic surgery under general anesthesia
  • Expected tracheal extubation during daytime working hours (before 4:00 PM)
Not Eligible

You will not qualify if you...

  • Refuse to participate in the study
  • Morbid obesity with body mass index 35 kg/m² or higher
  • Preoperative diagnosis of obstructive sleep apnea or STOP-Bang score 3 or more with serum bicarbonate 28 mmol/L or higher
  • High risk of difficult airway identified before surgery
  • Preexisting severe heart rhythm disorders without pacemaker or severe cardiovascular diseases with NYHA class III or higher
  • Significant lung function impairment with FEV1/FVC ratio below 70% and total lung capacity or vital capacity below 80% of predicted
  • Severe liver dysfunction (Child-Pugh class C), severe kidney dysfunction (eGFR below 30 mL/min/1.73 m²), or ASA physical status class IV or higher
  • Preoperative diagnosis of schizophrenia, epilepsy, Parkinson's disease, or myasthenia gravis
  • Unable to communicate due to coma, severe dementia, or language difficulties
  • Planned postoperative admission to intensive care unit
  • Any other conditions deemed unsuitable for study participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Peking University Fist Hospital

Beijing, Beijing Municipality, China, 100034

Actively Recruiting

Loading map...

Research Team

D

Dong-Xin Wang, MD, PhD

CONTACT

T

Ting Ding, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here